In light of the decision by CMS, do you question the FDA's decisionmaking regarding Aduhelm's accelerated approval?
Editor's note · Context
Senator Collins questions the FDA's decision-making after CMS's coverage determination.
Share
More from Susan Collins
While the investigation of the Biddeford shooting is not yet complete, it raises sufficient critical questions that I spoke with DHS Secretary Mullin last night and urged him to cease all non-urgent vehicle stops.
What appears to have happened is that there now has been ... somewhat of an increase of ICE activities before the additional training and body-worn cameras were deployed.
They don’t have them yet. The orders were placed, but they couldn ’t [process] the orders when the government was shut down.
I find this deeply troubling. Reports that women and people of color are disproportionately fired or sidelined create the impression that their service is not valued.





